News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
108last 24h
3128last 7d
512● bullish (7d)
311● bearish (7d)
227publishers
Simply Wall St.1d agoneutral
Hims & Hers Health (HIMS) Could Be 85% Undervalued Following The Eli Lilly DealSimply Wall St.1d agoneutral
Hims & Hers Stock After Lilly Weight Loss Drug Deal Has The Bull Case Changed?Simply Wall St.1d agoneutral
Hims & Hers Health (HIMS) Adds FDA Approved Obesity Drugs To Its PlatformInvesting.com2d agobullish
Hims & Hers stock climbs on direct partnership with Eli Lilly for obesity drugsInvestor's Business Daily2d agobullish
Hims & Hers Surges On 'Surprising And Inevitable' Deal With Eli LillyBarrons.com2d agoneutral
Why Hims & Hers Health Stock Was in Dire Need of This Eli Lilly AgreementInvestorsHub2d agoneutral
Eli Lilly Partners With Hims & Hers to Expand Access to Obesity Treatments Through TelehealthMT Newswires2d agoneutral
Eli Lilly, Hims & Hers Health Expand Patient Access to Zepbound, FoundayoBusiness Wire2d agoneutral
Lilly and Hims & Hers expand access to FDA-approved Lilly medicines